Hospital
Uchealth Greeley Hospital
Uchealth Greeley Hospital was paid $5.86M by Medicaid between Jul 2019 and Dec 2024, across 78 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.
33Billing provider infoUCHEALTH GREELEY HOSPITAL
GREELEY, CO 80634
GREELEY, CO 80634
33aNPI1780183145assigned 02/12/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.86M
24GClaims145,359
24DCodes billed78
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#19 of 51
Median peer was paid$1.24M
This provider vs. median4.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMPSON, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 3,043 | $125K | |
| 2020 | 18,496 | $639K | |
| 2021 | 27,764 | $961K | |
| 2022 | 30,645 | $1.37M | |
| 2023 | 38,341 | $1.61M | |
| 2024incomplete | 27,070 | $1.16M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 12,654 | 11,900 | $1.60M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26% | 13,700 | 12,716 | $1.51M |
| 96361 | Intravenous infusion, hydration; each additional hour | 21% | 4,291 | 3,926 | $1.25M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 7,646 | 7,141 | $868K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.9% | 2,241 | 2,174 | $171K |
| 80053 | Comprehensive metabolic panel | 1.9% | 10,920 | 9,959 | $112K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 154 | 146 | $52K |
| 0002A | <1% | 524 | 496 | $45K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,269 | 3,962 | $43K |
| 0001A | <1% | 376 | 354 | $32K | |
| 84484 | <1% | 1,084 | 902 | $22K | |
| 86140 | <1% | 1,339 | 1,298 | $21K |
66 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 91 | $20K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 299 | $18K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,823 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,165 | $14K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 994 | $9K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 14 | $7K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 95 | $6K |
| 85652 | <1% | 1,346 | $5K | |
| 59025 | Fetal non-stress test | <1% | 37 | $5K |
| 85027 | <1% | 1,294 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 12 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 27 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,662 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 14 | $2K |
| J3490 | Unclassified drugs | <1% | 21,280 | $2K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 528 | $1K |
| 73130 | <1% | 21 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 25 | $1K |
| 80061 | Lipid panel | <1% | 194 | $1K |
| 86769 | <1% | 25 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 18 | $914.10 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,772 | $845.69 |
| 73564 | <1% | 25 | $819.87 | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,431 | $762.14 |
| 86200 | <1% | 15 | $526.20 | |
| 80076 | <1% | 144 | $451.50 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 49 | $428.66 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 121 | $360.25 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,597 | $355.73 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 204 | $299.65 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 500 | $292.51 |
| 86780 | <1% | 50 | $217.89 | |
| 80306 | <1% | 52 | $201.56 | |
| 81001 | <1% | 1,961 | $118.15 | |
| 81025 | <1% | 196 | $108.33 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 17 | $72.33 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $53.46 |
| 83690 | <1% | 1,079 | $6.89 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,367 | $6.36 |
| 81003 | <1% | 111 | $1.96 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,464 | $1.35 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 675 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 925 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 51 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 104 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 13 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 13 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 0% | 14 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,186 | $0.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 0% | 54 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 28 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 62 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 191 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 109 | $0.00 |
| 84703 | 0% | 156 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 108 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 28 | $0.00 |
| 83735 | 0% | 27 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 54 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 17 | $0.00 |
| A4364 | Adhesive, liquid or equal, any type, per oz | 0% | 58 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 54 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 29 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 29 | $0.00 |
| 82077 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMPSON, DAVID (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.